Literature DB >> 6748560

Reversible hypertension in primary hyperparathyroidism--pre- and posteroperative blood pressure in 75 cases.

J D Ringe.   

Abstract

In 75 operatively proved cases of primary hyperparathyroidism (PH) mean systolic and diastolic blood pressure (BP) values were significantly higher pre- than postoperatively. There were 27 patients (36%) who showed hypertension before operation (systolic BP greater than or equal to 150 mm Hg, mean 169 +/- 20 mm Hg). In 20 of these the hypertension was reversible after successful treatment of PH, in seven cases elevated values persisted. The mean age of patients with persisting hypertension was significantly higher than the group with normalization of BP after operation (P less than 0.01). As far as clinical presentation of PH was concerned it were those cases with hypercalcaemic syndrome and with accidentally discovered hypercalcaemia who most often showed hypertension. In cases with recurrent urolithiasis and with osteitis fibrosa as leading symptoms there was no significant increase of hypertension as compared to the whole group. Because of the relatively high incidence of hypertension in PH this possibility should be taken into consideration in each diagnostic clarification of hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6748560     DOI: 10.1007/BF01726908

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  22 in total

1.  Hypertension in hyperparathyroidism.

Authors:  J HELLSTROM; G BIRKE; C A EDVALL
Journal:  Br J Urol       Date:  1958-03

2.  Calcium and blood pressure.

Authors:  H Kesteloot; J Geboers
Journal:  Lancet       Date:  1982-04-10       Impact factor: 79.321

3.  Slow channel inhibitors verapamil and nifedipine in the management of hypertension.

Authors:  B A Gould; R S Hornung; S Mann; V Balasubramanian; E B Raftery
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

4.  Effect of magnesium on blood pressure.

Authors:  T Dyckner; P O Wester
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-11

5.  Reversible hypertension. Caused by the hypercalcemia of hyperparathyroidism, vitamin D toxicity, and calcium infusion.

Authors:  M Blum; M Kirsten; M H Worth
Journal:  JAMA       Date:  1977-01-17       Impact factor: 56.272

6.  Blood pressure in subjects with hypercalcaemia and primary hyperparathyroidism detected in a health screening programme.

Authors:  T Christensson; K Hellström; B Wengle
Journal:  Eur J Clin Invest       Date:  1977-04       Impact factor: 4.686

7.  Effect of parathyroid hormone on plasma renin activity and sodium excretion.

Authors:  J M Smith; D R Mouw; A J Vander
Journal:  Am J Physiol       Date:  1979-03

8.  Hypertension and hyperparathyroidism.

Authors:  F D Rosenthal; S Roy
Journal:  Br Med J       Date:  1972-11-18

9.  Reduction of blood pressure with calcium supplementation in young adults.

Authors:  J M Belizan; J Villar; O Pineda; A E Gonzalez; E Sainz; G Garrera; R Sibrian
Journal:  JAMA       Date:  1983-03-04       Impact factor: 56.272

10.  Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension.

Authors:  N Beer; I Gallegos; A Cohen; N Klein; E Sonnenblick; W Frishman
Journal:  Chest       Date:  1981-05       Impact factor: 9.410

View more
  8 in total

Review 1.  Mild primary hyperparathyroidism: a literature review.

Authors:  Megan K Applewhite; David F Schneider
Journal:  Oncologist       Date:  2014-07-25

2.  [Clinical experiences following the surgical therapy of asymptomatic, oligosymptomatic and symptomatic parathyroid gland hyperfunction].

Authors:  B Niederle; R Roka; J Kovarik; K Klaushofer; G Schernthaner; A Fritsch
Journal:  Klin Wochenschr       Date:  1986-10-01

Review 3.  Cardiovascular aspects of primary hyperparathyroidism.

Authors:  M D Walker; S J Silverberg
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

Review 4.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

5.  [Calcium-free hemodialysis--value in therapy of hypercalcemic crisis].

Authors:  W Kaiser; G Biesenbach; R Kramar; J Zazgornik
Journal:  Klin Wochenschr       Date:  1989-01-20

6.  The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis.

Authors:  Maryam Yavari; Awat Feizi; Fahimeh Haghighatdoost; Azin Ghaffari; Hassan Rezvanian
Journal:  Endocrine       Date:  2020-10-15       Impact factor: 3.633

Review 7.  Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.

Authors:  Jenifer M Brown; Anand Vaidya
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-06       Impact factor: 3.243

Review 8.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Shonni J Silverberg; E Michael Lewiecki; Leif Mosekilde; Munro Peacock; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.